Cargando…
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483498/ https://www.ncbi.nlm.nih.gov/pubmed/32917263 http://dx.doi.org/10.1186/s13054-020-03277-8 |
_version_ | 1783580929404436480 |
---|---|
author | Honore, Patrick M. Redant, Sebastien De Bels, David |
author_facet | Honore, Patrick M. Redant, Sebastien De Bels, David |
author_sort | Honore, Patrick M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7483498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74834982020-09-11 Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not Honore, Patrick M. Redant, Sebastien De Bels, David Crit Care Editorial BioMed Central 2020-09-11 /pmc/articles/PMC7483498/ /pubmed/32917263 http://dx.doi.org/10.1186/s13054-020-03277-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Editorial Honore, Patrick M. Redant, Sebastien De Bels, David Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title | Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title_full | Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title_fullStr | Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title_full_unstemmed | Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title_short | Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
title_sort | reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483498/ https://www.ncbi.nlm.nih.gov/pubmed/32917263 http://dx.doi.org/10.1186/s13054-020-03277-8 |
work_keys_str_mv | AT honorepatrickm reliabilityofbiomarkersofsepsisduringextracorporealtherapiestheclinicianneedstoknowwhatiseliminatedandwhatisnot AT redantsebastien reliabilityofbiomarkersofsepsisduringextracorporealtherapiestheclinicianneedstoknowwhatiseliminatedandwhatisnot AT debelsdavid reliabilityofbiomarkersofsepsisduringextracorporealtherapiestheclinicianneedstoknowwhatiseliminatedandwhatisnot |